MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-10692

  1. 7,881 Posts.
    lightbulb Created with Sketch. 624
    We must point that out to you know who because he has been arguing that the cost of Rem-l is too expensive vis-a-vis ICU & Ventilation and the benefits are minimal
    A huge bill and death versus a smaller bill and you live
    Well that bill certainly blows his argument out of the water
    Last edited by stocksa: 24/08/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.